By Alexandra Harney and Michael Erman SHANGHAI/NEW YORK (Reuters) - The U.S. Food and Drug Administration said on Friday it will no longer allow imports of drug ingredients or medicines made with ingredients produced by China's Zhejiang Huahai Pharmaceuticals, after a recall of one of its drugs that contained a probable carcinogen
from Latest News Business on Firstpost https://ift.tt/2QmwT8T
Saturday, 29 September 2018
FDA halts imports from China's Huahai after heart drug recall
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment